πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda β€” grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≀24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months β€” use filters for patent-cliff planning.

Page 17 of 30

  1. US 8552198

    Benzimidazole compound crystal

    Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8541456

    Roflumilast for the treatment of diabetes mellitus type 2

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8541024

    Film-coated scored tablet

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8541417

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8536206

    Process for the preparation of roflumilast

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8530499

    Glucokinase activators

    Expires Mon Sep 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8519002

    Colchicine solid complex; methods of making; and methods of use thereof

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8518890

    Remedies for sex hormone dependent disease

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8513251

    Pyridazinone compounds

    Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8501750

    Heterocyclic compound and use thereof

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8501804

    Bicyclic compound

    Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8497274

    Heterocyclic compound and use thereof

    Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8497290

    Thiocolchicine derivatives, method of making and methods of use thereof

    Expires Mon Jul 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8492430

    Fused cyclic compounds

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8492378

    GSK-3Ξ² inhibitor

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8492405

    Glucokinase-activating fused heterocyclic compounds and methods of treating diabetes and obesity

    Expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8486923

    Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8486450

    Method of producing solid preparation disintegrating in the oral cavity

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8486965

    Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8481516

    Ciclesonide containing sterile aqueous suspension

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8481569

    Iminopyridine derivatives and use thereof

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8481693

    Virus like particle purification

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8470837

    MAPK/ERK kinase inhibitors

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8470859

    Iminopyridine derivative and use thereof

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8470816

    Nitrogen-containing heterocyclic compound and use thereof

    Expires Mon Jun 20 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8466282

    Heterocyclic compound and use thereof

    Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8465767

    Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles

    Expires Mon Jun 13 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8461163

    Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8461348

    Heterocyclic derivative and use thereof

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8461187

    Multiple PPI dosage form

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8455653

    Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

    Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8450339

    Compositions for treatment of common cold

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8449911

    Drug composition having active ingredient adhered at high concentration to spherical core

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8450070

    Method for screening of cell-protecting agent

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8450323

    Substituted derivatives of pyrido[3,2-e][1,4]thiazino[4,3-a]pyrazine and pyrido[3,2-e][1,4]oxazino[4,3-a]pyrazine

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8445509

    Fused heterocyclic derivatives and use thereof

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8445541

    Methods for concomitant administration of colchicine and a second active agent

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8445461

    Pharmaceutical composition for meniere's disease

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8445501

    Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8440721

    Methods for concomitant administration of colchicine and a second active agent

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8440210

    Stabilized pharmaceutical product

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8440689

    Fused heteroaromatic pyrrolidinones

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8440722

    Methods for concomitant administration of colchicine and a second active agent

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8436043

    Heterocyclic compound

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8435995

    Pyridazinone compounds

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8435497

    Formoterol of and ciclesonide combination

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8436187

    1-heterocyclylsulfonyl, 3-aminomethyl, 5- (hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8436200

    Process for making (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro-4- iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione and intermediates thereof

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.